FDA Releases Draft Revisions to Blood Donor Eligibility Evaluations

The FDA has released draft guidelines revising recommendations for evaluating blood donor eligibility. The proposed evaluative guidelines will include gender-inclusive, individual risk-based questions intended to reduce the risk of transfusion-transmitted HIV.  

“Maintaining a safe and adequate supply of blood and blood products in the U.S. is paramount for the FDA,” said FDA Commissioner Robert M. Califf, M.D. “This proposal for an individual risk assessment, regardless of gender or sexual orientation, will enable us to continue using the best science to do so.”  

If finalized, the proposed guidelines will expand the potential donor pool while maintaining protections to the U.S. blood supply.

Join our email list

Get new course alerts, newsletters and more delivered directly to your inbox

By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.